These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 10500570)

  • 41. Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.
    Fabrega AJ; Corwin CL; Hunsicker L
    Transplant Proc; 1998 Jun; 30(4):1562-3. PubMed ID: 9636634
    [No Abstract]   [Full Text] [Related]  

  • 42. Mycophenolate mofetil in ongoing chronic kidney allograft dysfunction.
    Senn B; Rochat P; Schwarzkopf AK; Weinreich T; Binswanger U
    Transplant Proc; 1998 Dec; 30(8):4075-6. PubMed ID: 9865301
    [No Abstract]   [Full Text] [Related]  

  • 43. Lymphocyte subsets in renal transplant recipients treated with mycophenolate mofetil.
    François M; Büchler M; Halimi JM; Al-Najjar A; Valentin JF; Thibault G; Lebranchu Y
    Transplant Proc; 2000 Dec; 32(8):2781-2. PubMed ID: 11134803
    [No Abstract]   [Full Text] [Related]  

  • 44. Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
    Miller J
    Transplant Proc; 1999; 31(1-2):276-7. PubMed ID: 10083106
    [No Abstract]   [Full Text] [Related]  

  • 45. Place of mycophenolate mofetil in renal transplantation.
    Grinyó JM
    Transplant Proc; 2001; 33(1-2):997-9. PubMed ID: 11267162
    [No Abstract]   [Full Text] [Related]  

  • 46. Mycophenolate mofetil-based immunosuppressive therapy: induction, maintenance, and conversion protocols in renal transplantation.
    Land W
    Transplant Proc; 1999 Dec; 31(8A):27S-32S. PubMed ID: 10616558
    [No Abstract]   [Full Text] [Related]  

  • 47. Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.
    Höcker B; John U; Plank C; Wühl E; Weber LT; Misselwitz J; Rascher W; Mehls O; Tönshoff B
    Transplantation; 2004 Jul; 78(2):228-34. PubMed ID: 15280683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression.
    Tsai MK; Hu RH; Lee CJ; Lee PH
    J Formos Med Assoc; 2002 Sep; 101(9):616-21. PubMed ID: 12645188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment with mycophenolate mofetil in kidney transplant patients with organs from donors aged over 60 years: one-year monitoring results.
    Agraz I; Guirado L; Andrade M; Olaya M; Vila A; Solá R
    Transplant Proc; 1999 Sep; 31(6):2272-4. PubMed ID: 10500573
    [No Abstract]   [Full Text] [Related]  

  • 50. Single center analysis of mycophenolate mofetil and Neoral/prednisone therapy for prophylaxis of rejection in African-American and Caucasian transplant recipients.
    Weber M; Ketchum RJ; Sellers M; Aradhye S; Deng S; Grossman R; Shaw L; Naji A; Barker C; Brayman KL
    Transplant Proc; 1997; 29(1-2):338-9. PubMed ID: 9123029
    [No Abstract]   [Full Text] [Related]  

  • 51. Mycophenolate mofetil in renal transplantation: five years experience.
    Tuncer M; Gürkan A; Erdoğan O; Demirbaş A; Süleymanlar G; Ersoy FF; Akaydin M; Yakupoğlu G
    Transplant Proc; 2002 Sep; 34(6):2087-8. PubMed ID: 12270324
    [No Abstract]   [Full Text] [Related]  

  • 52. Tacrolimus vs CyA Neoral in combination with MMF and steroids after cadaveric renal transplantation.
    Wang XH; Tang XD; Xu D
    Transplant Proc; 2000 Nov; 32(7):1702-3. PubMed ID: 11119899
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of severe acute vascular rejection in a renal allograft with mycophenolate mofetil and high dose steroids.
    Lafferty ME; Lang S; McGregor E; Henderson IS; Jones MC
    Scott Med J; 1997 Jun; 42(3):79-80. PubMed ID: 9351121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclosporine-sparing effect of basiliximab in renal transplant recipients with mycophenolate mofetil.
    Tojimbara T; Sato S; Koyama I; Nanmoku K; Sekijima M; Tonsyo M; Kai K; Kato Y; Urashima Y; Nakajima I; Fuchinoue S; Teraoka S
    Transplant Proc; 2005 Mar; 37(2):895-8. PubMed ID: 15848568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improvement in long-term graft survival in cadaveric renal transplant recipients treated with mycophenolate mofetil.
    Hazzan M; Provot F; Glowacki F; Copin MC; Roumilhac D; Labalette M; Pruvot FR; Noel C
    Transpl Int; 2004 Oct; 17(9):525-30. PubMed ID: 15338120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year.
    Duzova A; Buyan N; Bakkaloglu M; Dalgic A; Soylemezoglu O; Besbas N; Bakkaloglu A
    Transplant Proc; 2003 Dec; 35(8):2878-80. PubMed ID: 14697926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clear benefit of mycophenolate mofetil-based triple therapy in reducing the incidence of acute rejection after living donor renal transplantations.
    Kim YS; Moon JI; Kim SI; Park K
    Transplantation; 1999 Aug; 68(4):578-81. PubMed ID: 10480420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Canadian multicentre trial of tacrolimus/azathioprine/steroids versus tacrolimus/mycophenolate mofetil/steroids versus neoral/mycophenolate mofetil/steroids in renal transplantation.
    Busque S; Shoker A; Landsberg D; McAlister V; Halloran P; Shapiro J; Peets J; Schulz M
    Transplant Proc; 2001; 33(1-2):1266-7. PubMed ID: 11267285
    [No Abstract]   [Full Text] [Related]  

  • 59. Safety and efficacy of mycophenolate mofetil for prophylaxis in Asian renal transplant recipients.
    Suhail SM; Vathsala A; Lou HX; Woo KT
    Transplant Proc; 2000 Nov; 32(7):1757-8. PubMed ID: 11119922
    [No Abstract]   [Full Text] [Related]  

  • 60. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.